Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162382 | SCV000212693 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000409557 | SCV000488553 | benign | Nijmegen breakage syndrome-like disorder | 2016-06-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000162382 | SCV000559094 | benign | Hereditary cancer-predisposing syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587341 | SCV000698655 | benign | not provided | 2016-05-24 | criteria provided, single submitter | clinical testing | Variant summary: The RAD50 c.3846T>C (p.Tyr1282Tyr) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool (MutationTaster) predicts a polymorphism outcome for this variant. This variant was found in 1833/121336 control chromosomes (146 homozygotes) at a frequency of 0.0151068, which is approximately 242 times the estimated maximal expected allele frequency of a pathogenic RAD50 variant (0.0000625), suggesting this variant is likely a benign polymorphism. It is a common polymorphism in African population with allele frequency of 16.52% (1717/10392 chromosomes) including 145 homozygotes. In addition, one clinical diagnostic laboratory classified this variant as benign. Taken together, this variant is classified as Benign. |
Gene |
RCV000587341 | SCV001856432 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002478494 | SCV002046732 | benign | not specified | 2021-03-16 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315975 | SCV004017227 | benign | Familial cancer of breast | 2023-07-07 | criteria provided, single submitter | clinical testing |